10 ml retatrutide 10mg Triple Agonist | GLP-1/GIP/Glucagon Retatrutide 24 mg & 40

Compounded GLP-1/GIP Our compounded tirzepatide injections are formulated to support your needs

Bottom line: Consistent tracking turns guesswork into actionable insights, helping you and your provider fine-tune your treatment plan for the best results

If you have questions, please contact our Provider Services Helpline at 1-888-991-9023 (Monday Friday, 9:00 a.m

It is not yet FDA-approved but has shown remarkable weight loss results in phase 2 trials, with participants losing up to 24.2% of body weight at the highest dose over 48 weeks

The glucagon receptor component in retatrutide likely drives the additional weight loss through increased energy expenditure and enhanced hepatic fat metabolism mechanisms not directly targeted by GLP-1 or GIP activation alone

doi: 10.1016/j.ymgmr.2014.07.009 86 SchaferSATschritterOMachicaoFThamerCStefanNGallwitzBet al